Loading stock data…
$0.19+0.00 (+2.48%)
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States.
KALA BIO, Inc. in the Healthcare sector is trading at $0.19 with a market capitalization of $10M. The stock is currently near its 52-week low of $0.12, remaining 97.5% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 0 is oversold, raising the odds of a near-term bounce. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$1.72M↑ | -$1.80M↑ | -$10.22M↓ | -$10.18M↑ | -$10.33M |
| Net Income | -$1.58M↑ | -$1.62M↓ | $686,000↑ | -$7.56M↑ | -$11.15M |
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic ...